secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2023-02-10T23:59:59+00:00
Accession:  0001104659-23-018503
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics amends bylaws, removes InvaGen special rights, changes quorum
--------------------------------------------------------------------------------

- Board adopted Second Amended and Restated Bylaws effective February 9, 2023.
- Removed all special rights and provisions previously granted to InvaGen Pharmaceuticals Inc.
- Quorum for stockholder meetings changed to majority of outstanding voting power.
- No immediate financial or operational impact disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923018503/0001104659-23-018503-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923018503/tm236264d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-018503

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer